cardiovascular and renal

https://adisinsight.springer.com/drugsafety/803925703?error=cookies_not_supported&code=3cc9ad6c-a6c0-45ee-9e69-b347347f2f0f Cardiovascular and renal AEs with tirzepatide versus dulaglutide - AdisInsight Tirzepatide is associated with a lower incidence of cardiovascular (CV) and renal adverse events (AEs) than dulaglutide in patients with type 2 diabetes cardiovascular and renal aes tirzepatide versus dulaglutide https://pmc.ncbi.nlm.nih.gov/articles/PMC11411209/ Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian... To assess the comparative cardiovascular and renal effectiveness and safety of empagliflozin vs. dapagliflozin among patients with type 2 diabetes in routine... cardiovascular and renal comparative effectiveness empagliflozin dapagliflozin https://pmc.ncbi.nlm.nih.gov/articles/PMC6164974/ Role of Nitric Oxide in the Cardiovascular and Renal Systems - PMC The gasotransmitters are a family of gaseous signaling molecules which are produced endogenously and act at specific receptors to play imperative roles in... cardiovascular and renal nitric oxide in the role https://www.repository.cam.ac.uk/items/7c2397e4-f921-4aea-83a6-bcdf29a2c9f1 Cardiovascular and renal effects of apelin in chronic kidney disease: a randomised, double-blind,... Chronic kidney disease (CKD) affects ~10% of the population and cardiovascular disease is its commonest complication. Despite treatment, patient outcomes... cardiovascular and renal https://scholars.duke.edu/publication/708043 Scholars@Duke publication: Cardiovascular and renal toxicity of a nonionic radiographic contrast... cardiovascular and renal

Robuta